Peter Voorhees

34PUBLICATIONS
158CO-AUTHORS
Planning and decision makingRegenerative medicine (incl. stem cells)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jun 01, 2026
Expert Validation of an Artificial Intelligence-Enabled Trial Matching Solution Using Real-World Data From Patients With Cancer.

|Mar 26, 2026
Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab: A Panel Chart Review Study.

Binod Dhakal, Moshe Y Levy, Gilbert Ko

|Feb 20, 2026
Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myeloma.

Shebli Atrash, James Symanowski, Myra Robinson

|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough, Danai Dima, Beatrice Razzo

|Nov 21, 2025
Outcomes of CAR T-Cell therapy in relapsed/refractory multiple myeloma by race: a multicenter real-world study.

Manisha Bhutani, Alma Habib, Andrew Vegel

|Oct 06, 2025
Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.

Laahn Foster, Larry D Anderson, Alfred Chung

Pageof 6

Frequent Collaborators

16 joint publications

Larry D Anderson

12 joint publications

Surbhi Sidana

12 joint publications

Krina Patel

12 joint publications

Douglas W Sborov